Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
140.8 USD | +0.93% | -1.80% | +19.68% |
Apr. 26 | CR Double-Crane Pharmaceutical's Profit Rises 11% in Q1 as Revenue Grows 2% | MT |
Apr. 26 | CR Double-Crane Pharmaceutical's Unit Gets Nod to Trial New Pain Medication | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.68% | 7.96B | |
+4.41% | 15.09B | |
-25.48% | 11.22B | |
+34.56% | 1.96B | |
+2.36% | 1.5B | |
+27.24% | 982M | |
+9.62% | 918M | |
+10.28% | 751M | |
-8.27% | 677M | |
-20.25% | 407M |
- Stock Market
- Equities
- CR Stock
- News Crane Company
- CR Double-Crane Pharmaceutical Gets Nod to Trial Semaglutide Injection